Stockreport

Anixa Biosciences administers second CAR-T dose in ovarian cancer trial [Yahoo! Finance]

Anixa Biosciences, Inc.  (ANIX) 
Last anixa biosciences, inc. earnings: 3/9 05:10 pm Check Earnings Report
PDF T-cell (CAR-T) therapy to a patient in a Phase I clinical trial for ovarian cancer. This development follows the patient's positive response to the initial treatment. [Read more]